DrugPatentWatch Database Preview
Tolmar Company Profile
What is the competitive landscape for TOLMAR, and when can generic versions of TOLMAR drugs launch?
There are ten US patents protecting TOLMAR drugs.
There are sixty-seven patent family members on TOLMAR drugs in twenty-six countries and twenty-three supplementary protection certificates in eight countries.
Summary for Tolmar
| International Patents: | 67 |
| US Patents: | 10 |
| Tradenames: | 22 |
| Ingredients: | 22 |
| NDAs: | 31 |
| Patent Litigation for Tolmar: | See patent lawsuits for Tolmar |
Drugs and US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021731-001 | Dec 14, 2004 | RX | Yes | Yes | 9,914,802 | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Tolmar | CALCIPOTRIENE | calcipotriene | CREAM;TOPICAL | 200935-001 | May 30, 2012 | AB | RX | No | No | ➤ Sign Up | ➤ Sign Up | ||||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 6,773,714 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | RX | Yes | Yes | 6,565,874 | ➤ Sign Up | Y | ➤ Sign Up | |||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Expired US Patents for Tolmar
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,599,552 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021379-001 | Jul 24, 2002 | 5,739,176 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | 5,733,950 | ➤ Sign Up |
| Tolmar Therap | ELIGARD | leuprolide acetate | INJECTABLE;SUBCUTANEOUS | 021343-001 | Jan 23, 2002 | 5,739,176 | ➤ Sign Up |
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
Non-Orange Book US Patents for Tolmar
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 6,143,314 | Controlled release liquid delivery compositions with low initial drug burst | ➤ Sign Up |
| 6,630,155 | Controlled release liquid delivery compositions with low initial drug burst | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for Tolmar Drugs
Supplementary Protection Certificates for Tolmar Drugs
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| C/GB99/003 | United Kingdom | ➤ Sign Up | PRODUCT NAME: IMIQUIMOD; REGISTERED: UK EU/1/98/080/001 19980918 |
| 2008 00029 | Denmark | ➤ Sign Up | PRODUCT NAME: ADAPALEN, BENZOYLPEROXID |
| C0042 | Belgium | ➤ Sign Up | PRODUCT NAME: 2-(2-BENZOYL-SUBSTITUE)-1,3-CYCLOHEXANE-DIONES; REGISTRATION NO/DATE: 8452/B 19930121 |
| 269 | Luxembourg | ➤ Sign Up | PRODUCT NAME: AZELASTINE,OU UN SEL PHARMACEUTIQUEMENT ACCEPTABLE DE CELUICI,ET UN ESTER PHARMACEUTIQUEMENT ACCEPTABLE DE FLUTICASONE |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
Similar Applicant Names
Here is a list of applicants with similar names.
